Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Twenty-seven lymphomas of
mucosa-associated lymphoid tissue
(
MALT
) derived from distinct anatomical sites were tested for the presence of genetic lesions commonly involved in B-cell lymphomagenesis, including activation of proto-oncogenes (BCL-1, BCL-2, BCL-6, and c-MYC), disruption of tumor suppressor loci (
p53
, 6q), and infection by viruses [Epstein-Barr virus (EBV), and Kaposi's sarcoma-herpesvirus/human herpesvirus-8 (KSHV/HHV-8)]. Sixteen low-grade and 11 high-grade
MALT
-lymphomas were included in the study. The presence of genetic lesions was tested by a combination of molecular approaches, including Southern blot hybridization, polymerase chain reaction (PCR), and PCR-single strand conformation polymorphism followed by DNA direct sequencing. Alterations of BCL-1, BCL-2, or c-MYC, as well as infection by KSHV/HHV-8, scored negative in all
MALT
-lymphomas analysed. Conversely, rearrangements of BCL-6 and mutations of
p53
clustered with a fraction of high-grade
MALT
-lymphomas. Deletions of 6q occurred in selected cases of both low- and high-grade
MALT
-lymphomas, whereas a monoclonal infection by EBV was restricted to one single patient. These data corroborate the notion that the molecular pathogenesis of
MALT
-lymphomas differs substantially from that of nodal B-cell lymphomas. Occasionally, however, a proportion of high-grade
MALT
-lymphomas may harbor selected genetic lesions among the ones commonly involved in nodal B-cell lymphomagenesis.
...
PMID:Detection of BCL-6 rearrangements and p53 mutations in Malt-lymphomas. 939 80
The pathogenesis of gastric
mucosa-associated lymphoid tissue
(
MALT
) lymphoma is an intriguing issue and is thought to be closely related to Helicobacter pylori infection. Gastric
MALT lymphoma
is thought to progress from the reactive state to low-grade malignancy and sometimes to high-grade malignancy. In the present study, we examined immunohistochemically the expression of bcl-6 and
p53
proteins in gastric
MALT
and gastric diffuse large lymphoma without low-grade
MALT lymphoma
component (gastric DLL) to elucidate their role in high-grade transformation of low-grade
MALT lymphoma
. We detected bcl-6 protein only in the high-grade components in four of eight high-grade
MALT lymphoma
cases and in four of six gastric DLL cases. In contrast, none of 17 cases of low-grade
MALT lymphoma
expressed bcl-6 protein (P < .05).
p53 protein
was detected in the high-grade components in 6 of 8 high-grade
MALT lymphoma
cases and in 4 of 6 gastric DLL cases, but it was expressed in 2 of 17 cases of low-grade
MALT
lymphomas. All high-grade gastric
MALT
lymphomas cases were positive for
p53 protein
and/or bcl-6 protein. There is a tendency for an inverse relationship between bcl-6 protein and
p53 protein
. These findings suggest that high-grade transformation of gastric low-grade
MALT lymphoma
is associated with overexpression of
p53
or bcl-6 protein.
...
PMID:bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach. 950 89
Low grade B-cell non-Hodgkin's lymphomas (B-NHL) represent a markedly heterogeneous group of lymphoproliferative disorders, including B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CCL/SLL), lymphoplasmacytoid lymphoma (LPL), follicular lymphoma (FL),
mucosa-associated lymphoid tissue lymphoma
(MALTL), and splenic lymphoma with villous lymphocytes (SLVL). The molecular pathogenesis of low grade B-NHL is characterized by distinct genetic pathways which selectively associate with each clinicopathologic category. At diagnosis, B-CLL/SLL frequently display deletions of 13q14 and trisomy 12, whereas evolution to Richter's syndrome associates with disruption of
p53
. LPL carries t(9;14)(p13;q32) in 40-50% of the cases, leading to the deregulated expression of the PAX-5 gene. FL consistently harbors rearrangements of BCL-2 independent of the cytologic variant. With time, a fraction of FL cases accumulates mutations of
p53
and evolves into a high grade B-NHL. Low grade MALTL are characterized by the frequent occurrence of trisomy 3 and, occasionally, by
p53
mutations. SLVL carries
p53
mutations in a fraction of cases. The identification of distinct genetic categories among low grade B-NHL may help in the therapeutic stratification of these disorders. In addition, genetic lesions of low grade B-NHL have proved to be a useful molecular marker for monitoring minimal residual disease.
...
PMID:Molecular pathways in low grade B-cell lymphoma. 957 Jun 87
Hepatitis C virus (HCV) infection may be complicated by non-Hodgkin's lymphoma. We describe eight cases of B-cell extranodal non-Hodgkin's lymphoma occurring during the course of chronic HCV-related hepatic disease (low-grade of
mucosa-associated lymphoid tissue
[
MALT
]-type; diffuse large cell; Burkitt; diffuse small cell). Some were localized to the liver (2), liver and spleen (1), spleen (1), peritoneal cavity (1), parotid gland (1); others manifested in the nasopharynx (1) and eyelid (1) but were accompanied by nodal disease. Four lymphomatous specimens available for molecular analysis exhibited clonal immunoglobulin gene rearrangements, lacked bcl-2, bcl-6, c-myc genes and
p53
alterations, and did not contain replicative intermediate HCV RNA, as documented by a strand-specific reverse transcriptase-polymerase chain reaction. Low levels of positive-strand HCV RNA were detected in a single hepatic lymphoma, suggesting the presence of the virus in residual hepatocytes. The antigen-driven properties of HCV-associated B-cell malignant neoplasms may be considered for hepatic
MALT
-type lymphoma, which probably originated from lymphoid tissue acquired during long-standing HCV infection.
...
PMID:Extranodal lymphomas associated with hepatitis C virus infection. 957 65
Replication error (RER) phenotype, caused by deficiency of DNA mismatch repair genes and revealed by widespread microsatellite instability, has been detected in subsets of a wide variety of solid tumors, but rarely in lymphomas in general. So far, the involvement of RER phenotype in the pathogenesis of gastric lymphoma of
mucosa-associated lymphoid tissue
(
MALT
) type has not been conclusively established. We therefore examined 9 microsatellite loci on 5 chromosomes [D2S123, D3S11, D3S1261, D3S1262, D3S1265, D6S262, D18S559, a CTTT(T) repeat in intron 20 of RBI gene and a CA repeat in
p53
locus] in 33 cases of primary gastric
MALT lymphoma
for evidence of microsatellite instability by polymerase chain reaction using primers end-labeled with [gamma-33P] ATP. Although novel-length allele was observed in 7 of 33 cases (21.2%), none of these 7 cases showed changes in more than one locus. RER phenotype was scored as positive in a case when more than 1 of the 9 examined microsatellite loci showed length alterations. Accordingly, none of the 33 cases had a RER phenotype. This result suggests that the pathogenesis of gastric
MALT lymphoma
does not involve RER phenotype. It is consistent with the general observations in lymphomas, but is highly in contrast to a previous report showing more than 50% of
MALT
lymphomas with the RER phenotype.
...
PMID:No evidence of replication error phenotype in primary gastric lymphoma of mucosa-associated lymphoid tissue. 961 Jul 18
The evolution of gastric
mucosa-associated lymphoid tissue
(
MALT
) lymphoma is a multi-stage process, comprising the sequential development of chronic H. pylori-associated gastritis, low grade and high grade lymphoma. The genesis of
MALT lymphoma
embodies the mechanisms of both physiological immune responses and the acquisition of genetic abnormalities. The tumour probably originates from an autoreactive
MALT
marginal zone B cell, which is generated during H. pylori infection. As a consequence of a genotoxic insult induced by H. pylori infection, the progenitor tumour cell may become genetically unstable and develop genetic abnormalities such as the t(11;18) translocation, trisomy three, c-myc and
p53
mutations during a phase of expansion, which lead to partial transformation. With the growth help from H. pylori specific T cells, this abnormal B cell clone may undergo clonal expansion and gradually form a low grade
MALT lymphoma
. Additional genetic abnormalities including the t(1;14) translocation and other uncharacterised events could completely transform this abnormal B cell clone and result in escape from T cell dependency. Finally, further genetic events such as complete inactivation of the tumour suppressor genes
p53
and p16, and possible activation of c-myc oncogene by translocation or other undetermined abnormalities can result in high grade transformation
...
PMID:Recent advances in our understanding of the biology and pathogenesis of gastric mucosa-associated lymphoid tissue (malt) lymphoma. 966 52
We have investigated by immunohistochemistry 38 cases of B-cell
MALT
-NHL comprising 23 high grade (HG) and 15 low grade-(LG) tumours for the expression of
p53
, mdm2, p21, Rb, Ki67, bcl2 and Bax proteins.
P53
, mdm2 and p21 proteins were found in at least 5% of the tumour cells in 13/23, 2/23 and 11/23 HG tumours, respectively. These proteins were detected in very rare tumour cells in LG tumours. The following patterns were recorded in HG tumours: p53+/p21+/mdm2+ (2 cases), p53+/p21+/mdm2- (7 cases), p53+/p21-/mdm2- (4 cases),
p53
-/p21-/mdm2- (18 cases) and
p53
-/p21+/mdm2-(2 cases). Proliferative Ki67 index and Rb protein expression were higher in HG than in LG
MALT
-NHL. Bcl2 protein was expressed in all LG
MALT
-NHL, whereas only 2/23 HG
MALT
-NHL were bcl2 positive in most tumour cells. Bax protein was expressed in all
MALT
-NHL with HG tumours being positive in higher proportion of tumour cells than LG tumours. These findings show that significant expression of
p53
, mdm2, p21,Ki67 and Rb proteins occurs more frequently in aggressive histotypes of
MALT
-NHL. The parallel Rb/Ki67 expression suggests that Rb protein expression in
MALT
-NHL is normally regulated in relation to the proliferative growth fraction of the tumours. The pattern p53+/p21+/mdm2 +/- may represent
MALT
-NHL with wild type (wt)
p53
gene since mdm2 and p21 proteins are inducible by wt
p53
gene. The pattern p53+/mdm2-/p21-may represent
MALT
-NHL with
p53
gene mutations unable to activate expression of mdm2 and p21 proteins.
MALT
-NHL with the
p53
-/mdm2-/p21 + pattern may be consistent with
p53
-independent p21 expression. Bax protein expression in all
MALT
-NHL suggests a role for this protein in the pathogenesis of these tumours.
...
PMID:Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue. 970 86
Gastric low-grade
mucosa-associated lymphoid tissue
(
MALT
) lymphoma is a unique disease. A vast majority of lymphoma cells are centrocyte-like cells or resemble monocytoid B cells, and occasionally show plasmacytic differentiation. Immunophenotypical and immunogenotypical examinations have indicated that they are in the differentiation stage of memory B cells, whose normal counterparts are marginal zone lymphocytes or monocytoid B cells in the lymphoid tissues. It arises from chronic gastritis closely associated with Helicobacter pylori (H. pylori) infection. Mucosa-associated lymphoid tissue lymphomas of other organs are also based on acquired
MALT
associated with chronic inflammation or autoimmune diseases. Interestingly, the majority of gastric low-grade
MALT
lymphomas regress by the eradication of H. pylori. The lymphoma cells, however, are not derived from B cells reacting with H. pylori itself but from autoreactive B cells. Although the mechanism of their oncogenesis has not been clarified, previous data suggest that autoreactive B cells proliferate in response to H. pylori-specific T cells, presumably with some cytokines. The genetic instability of such B cells then induces chromosomal abnormalities including trisomy 3 and/or other genetic changes. These B cells have the ability of autonomic proliferation and, even so, they might be sensitive to T cell stimuli. Low-grade gastric lymphomas occasionally progress to high-grade malignancy. The high-grade component of
MALT
lymphomas are composed of large-sized lymphoma cells that are morphologically indistinguishable from nodal large B cell lymphomas. This high-grade transformation is associated with
p53
abnormalities or Bcl-6 overexpression. Gastric
MALT lymphoma
may provide a useful model in understanding multistep lymphomagenesis.
...
PMID:Gastric low-grade mucosa-associated lymphoid tissue lymphomas: their histogenesis and high-grade transformation. 970 38
The aim of this study is to present a histopathologic and immunohistochemical analysis of primary gastric lymphomas which were reclassified according to the concept of mucosa associated lymphoid tissue (MALT). The resected specimens from 41 patients with primary gastric lymphoma were investigated retrospectively. Immunohistochemical study was done to analyze the immunophenotype and bcl-2 and
p53
proteins expression. Twenty three of the cases had tumors mainly located in the antrum. Histologically, 12 were low grade and 20 were high grade B-cell lymphoma of MALT, 9 other B-cell nonHodgkin's lymphomas. Helicobacter pylori was identified in 72% of the cases. According to Musshoff's modification, most of the
MALT lymphoma
cases had stage I or II disease. There was significant difference between low and high grade cases, in respect to depth of invasion in gastric wall. Immunohistochemically, the neoplastic cells in all MALT lymphomas expressed B-cell phenotype. Bcl-2 protein was found to be expressed in 59% and
p53 protein
expression was detected in 72% of cases. Among the B-cell lymphoma of MALT, bcl-2 positivity decreased and
p53
positivity increased significantly as the histological grade advanced. So, an inverse correlation was observed between the expression of bcl-2 and
p53
. In conclusion, most primary gastric lymphomas are low or high grade B-cell MALT lymphomas and appear to arise in MALT acquired as a reaction to Helicobacter pylori infection. Expression of bcl-2 and
p53
in gastric lymphomas may be associated with transformation from low-grade to high-grade disease.
...
PMID:Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas. 1007 76
Gastric
MALT
lymphomas are clinically and histologically quite distinct from comparable low-grade B-cell lymphomas of lymph nodes. Their histology suggests that immunological mechanisms might be operative in their growth. Given that there is normally no lymphoid tissue in gastric mucosa and that Helicobacter pylori (H. pylori), the only common bacterial antigen in the stomach, results in the accumulation of gastric
MALT
, the possibility that this organism is implicated in the pathogenesis of gastric lymphoma has been extensively investigated. It appears that most, but not necessarily all, gastric
MALT
lymphomas arise in
MALT
acquired in response to H. pylori infection and develop by stepwise accumulation of genetic abnormalities. Early molecular events in the evolution of gastric
MALT lymphoma
from 'acquired'
MALT
include trisomy 3, t(11;18)(q21;q21), genetic damage leading to genetic instability, as indicated by the so-called replication error repair (RER) phenotype, and both
p53
and c-myc mutations. At this stage in their development, the growth of the lymphomas is driven by contact between the neoplastic B cells and H. pylori specific intra-tumoral T cells. Eradication of H. pylori causes the tumour to enter a latent phase resulting in clinical regression. Later events, such as t(1;14)(p22;q32), appear to be linked to a capacity for autonomous growth, loss of sensitivity to H. pylori and dissemination of the lymphoma beyond the stomach and gastric lymph nodes. Cloning of the breakpoint in t(1;14) has allowed the identification of a new tumour suppresser gene, bc110. High grade transformation of
MALT lymphoma
has been associated with
p53
inactivation, deletions of p16 and t(8;14).
...
PMID:Gastric MALT lymphoma: from concept to cure. 1044 84
<< Previous
1
2
3
4
5
6
7
Next >>